Campbell Bradley L, President and CEO of Amicus Therapeutics ($FOLD), sold about $2.5 million in company shares on the open market five times over the past year. His latest sale occurred on March 2, 2026. These transactions rank 3,027th among 11,678 insiders, below the average of $8.6 million across roughly six sales per insider. He reported no open market purchases.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| March 2, 2026 | AMICUS THERAPEUTICS, INC. | $FOLD | Campbell Bradley L | President and CEO | S | Common Stock | 22500 | $14.35 | 998,680.0000 | 314,000,712 | 2.20% | 0.01% |
| Jan. 20, 2026 | AMICUS THERAPEUTICS, INC. | $FOLD | Campbell Bradley L | President and CEO | M | Stock Options (right to buy) | 75000 | $0.00 | 0.0000 | 308,533,548 | 100.00% | 0.02% |
| Jan. 20, 2026 | AMICUS THERAPEUTICS, INC. | $FOLD | Campbell Bradley L | President and CEO | S | Common Stock | 75000 | $14.31 | 1,021,180.0000 | 308,533,548 | 6.84% | 0.02% |
| Jan. 20, 2026 | AMICUS THERAPEUTICS, INC. | $FOLD | Campbell Bradley L | President and CEO | M | Common Stock | 75000 | $6.10 | 1,096,180.0000 | 308,533,548 | 7.34% | 0.02% |
| Dec. 26, 2025 | AMICUS THERAPEUTICS, INC. | $FOLD | Campbell Bradley L | President and CEO | F | Common Stock | 108602 | $14.25 | 1,021,180.0000 | 308,533,548 | 9.61% | 0.04% |
| Dec. 15, 2025 | AMICUS THERAPEUTICS, INC. | $FOLD | Campbell Bradley L | President and CEO | S | Common Stock | 77926 | $10.86 | 1,129,782.0000 | 308,533,548 | 6.45% | 0.03% |
| Dec. 15, 2025 | AMICUS THERAPEUTICS, INC. | $FOLD | Campbell Bradley L | President and CEO | M | Stock Options (right to buy) | 70426 | $0.00 | 0.0000 | 308,533,548 | 100.00% | 0.02% |
| Dec. 15, 2025 | AMICUS THERAPEUTICS, INC. | $FOLD | Campbell Bradley L | President and CEO | M | Common Stock | 70426 | $9.03 | 1,207,708.0000 | 308,533,548 | 6.19% | 0.02% |
| Dec. 1, 2025 | AMICUS THERAPEUTICS, INC. | $FOLD | Campbell Bradley L | President and CEO | M | Common Stock | 14587 | $9.03 | 1,151,869.0000 | 308,533,548 | 1.28% | 0.00% |
| Dec. 1, 2025 | AMICUS THERAPEUTICS, INC. | $FOLD | Campbell Bradley L | President and CEO | S | Common Stock | 14587 | $10.01 | 1,137,282.0000 | 308,533,548 | 1.27% | 0.00% |
| Dec. 1, 2025 | AMICUS THERAPEUTICS, INC. | $FOLD | Campbell Bradley L | President and CEO | M | Stock Options (right to buy) | 14587 | $0.00 | 70,426.0000 | 308,533,548 | 17.16% | 0.00% |
| Nov. 24, 2025 | AMICUS THERAPEUTICS, INC. | $FOLD | Campbell Bradley L | President and CEO | S | Common Stock | 14587 | $10.04 | 1,137,282.0000 | 308,533,548 | 1.27% | 0.00% |
| Nov. 24, 2025 | AMICUS THERAPEUTICS, INC. | $FOLD | Campbell Bradley L | President and CEO | M | Stock Options (right to buy) | 14587 | $0.00 | 85,013.0000 | 308,533,548 | 14.65% | 0.00% |
| Nov. 24, 2025 | AMICUS THERAPEUTICS, INC. | $FOLD | Campbell Bradley L | President and CEO | M | Common Stock | 14587 | $9.03 | 1,151,869.0000 | 308,533,548 | 1.28% | 0.00% |
| March 15, 2025 | AMICUS THERAPEUTICS, INC. | $FOLD | Campbell Bradley L | President and CEO | F | Common Stock | 13375 | $8.90 | 1,137,282.0000 | 300,116,081 | 1.16% | 0.00% |
| Feb. 19, 2025 | AMICUS THERAPEUTICS, INC. | $FOLD | Campbell Bradley L | President and CEO | S | Common Stock | 400 | $10.00 | 1,150,657.0000 | 300,116,081 | 0.03% | 0.00% |
| Feb. 19, 2025 | AMICUS THERAPEUTICS, INC. | $FOLD | Campbell Bradley L | President and CEO | M | Common Stock | 400 | $9.03 | 1,151,057.0000 | 300,116,081 | 0.03% | 0.00% |
| Feb. 19, 2025 | AMICUS THERAPEUTICS, INC. | $FOLD | Campbell Bradley L | President and CEO | M | Stock Options (right to buy) | 400 | $0.00 | 99,600.0000 | 300,116,081 | 0.40% | 0.00% |
| Feb. 11, 2025 | AMICUS THERAPEUTICS, INC. | $FOLD | Campbell Bradley L | President and CEO | A | Common Stock | 137075 | $0.00 | 1,220,768.0000 | 300,116,081 | 12.65% | 0.05% |
| Feb. 11, 2025 | AMICUS THERAPEUTICS, INC. | $FOLD | Campbell Bradley L | President and CEO | F | Common Stock | 70711 | $9.57 | 1,150,657.0000 | 300,116,081 | 5.79% | 0.02% |
| Jan. 3, 2025 | AMICUS THERAPEUTICS, INC. | $FOLD | Campbell Bradley L | President and CEO | F | Common Stock | 41474 | $9.41 | 1,091,061.0000 | 304,380,502 | 3.66% | 0.01% |
| Jan. 2, 2025 | AMICUS THERAPEUTICS, INC. | $FOLD | Campbell Bradley L | President and CEO | F | Common Stock | 20647 | $9.31 | 866,007.0000 | 304,380,502 | 2.33% | 0.01% |
| Jan. 3, 2025 | AMICUS THERAPEUTICS, INC. | $FOLD | Campbell Bradley L | President and CEO | A | Common Stock | 266528 | $0.00 | 1,132,535.0000 | 304,380,502 | 30.78% | 0.09% |
| Jan. 4, 2025 | AMICUS THERAPEUTICS, INC. | $FOLD | Campbell Bradley L | President and CEO | F | Common Stock | 7368 | $9.41 | 1,083,693.0000 | 304,380,502 | 0.68% | 0.00% |
| Jan. 3, 2025 | AMICUS THERAPEUTICS, INC. | $FOLD | Campbell Bradley L | President and CEO | A | Stock Options (right to buy) | 482908 | $0.00 | 482,908.0000 | 304,380,502 | 9999.99% | 0.16% |
| Dec. 2, 2024 | AMICUS THERAPEUTICS, INC. | $FOLD | Campbell Bradley L | President and CEO | M | Stock Options (right to buy) | 7500 | $0.00 | 0.0000 | 304,690,596 | 100.00% | 0.00% |
| Dec. 2, 2024 | AMICUS THERAPEUTICS, INC. | $FOLD | Campbell Bradley L | President and CEO | M | Common Stock | 7500 | $8.61 | 894,154.0000 | 304,690,596 | 0.85% | 0.00% |
| Dec. 2, 2024 | AMICUS THERAPEUTICS, INC. | $FOLD | Campbell Bradley L | President and CEO | S | Common Stock | 7500 | $10.02 | 886,654.0000 | 304,690,596 | 0.84% | 0.00% |
| Nov. 6, 2024 | AMICUS THERAPEUTICS, INC. | $FOLD | Campbell Bradley L | President and CEO | M | Stock Options (right to buy) | 7901 | $0.00 | 67,100.0000 | 304,690,596 | 10.53% | 0.00% |
| Nov. 6, 2024 | AMICUS THERAPEUTICS, INC. | $FOLD | Campbell Bradley L | President and CEO | S | Common Stock | 7901 | $12.50 | 886,654.0000 | 304,690,596 | 0.88% | 0.00% |
| Nov. 6, 2024 | AMICUS THERAPEUTICS, INC. | $FOLD | Campbell Bradley L | President and CEO | M | Common Stock | 7901 | $12.28 | 894,555.0000 | 304,690,596 | 0.89% | 0.00% |
| Nov. 1, 2024 | AMICUS THERAPEUTICS, INC. | $FOLD | Campbell Bradley L | President and CEO | M | Common Stock | 7500 | $8.61 | 894,154.0000 | 304,690,596 | 0.85% | 0.00% |
| Nov. 1, 2024 | AMICUS THERAPEUTICS, INC. | $FOLD | Campbell Bradley L | President and CEO | M | Stock Options (right to buy) | 7500 | $0.00 | 7,500.0000 | 304,690,596 | 50.00% | 0.00% |
| Nov. 1, 2024 | AMICUS THERAPEUTICS, INC. | $FOLD | Campbell Bradley L | President and CEO | S | Common Stock | 7500 | $11.46 | 886,654.0000 | 304,690,596 | 0.84% | 0.00% |
| Oct. 1, 2024 | AMICUS THERAPEUTICS, INC. | $FOLD | Campbell Bradley L | President and CEO | S | Common Stock | 7500 | $10.60 | 886,654.0000 | 304,690,596 | 0.84% | 0.00% |
| Oct. 1, 2024 | AMICUS THERAPEUTICS, INC. | $FOLD | Campbell Bradley L | President and CEO | M | Common Stock | 7500 | $8.61 | 894,154.0000 | 304,690,596 | 0.85% | 0.00% |
| Oct. 1, 2024 | AMICUS THERAPEUTICS, INC. | $FOLD | Campbell Bradley L | President and CEO | M | Stock Options (right to buy) | 7500 | $0.00 | 15,000.0000 | 304,690,596 | 33.33% | 0.00% |
| Sept. 3, 2024 | AMICUS THERAPEUTICS, INC. | $FOLD | Campbell Bradley L | President and CEO | S | Common Stock | 7500 | $11.71 | 886,654.0000 | 295,164,515 | 0.84% | 0.00% |
| Sept. 3, 2024 | AMICUS THERAPEUTICS, INC. | $FOLD | Campbell Bradley L | President and CEO | M | Common Stock | 7500 | $8.61 | 894,154.0000 | 295,164,515 | 0.85% | 0.00% |
| Sept. 3, 2024 | AMICUS THERAPEUTICS, INC. | $FOLD | Campbell Bradley L | President and CEO | M | Stock Options (right to buy) | 7500 | $0.00 | 22,500.0000 | 295,164,515 | 25.00% | 0.00% |
| Aug. 1, 2024 | AMICUS THERAPEUTICS, INC. | $FOLD | Campbell Bradley L | President and CEO | M | Common Stock | 7500 | $8.61 | 894,154.0000 | 295,164,515 | 0.85% | 0.00% |
| Aug. 1, 2024 | AMICUS THERAPEUTICS, INC. | $FOLD | Campbell Bradley L | President and CEO | M | Stock Options (right to buy) | 7500 | $0.00 | 30,000.0000 | 295,164,515 | 20.00% | 0.00% |
| Aug. 1, 2024 | AMICUS THERAPEUTICS, INC. | $FOLD | Campbell Bradley L | President and CEO | S | Common Stock | 7500 | $10.34 | 886,654.0000 | 295,164,515 | 0.84% | 0.00% |
| July 5, 2024 | AMICUS THERAPEUTICS, INC. | $FOLD | Campbell Bradley L | President and CEO | S | Common Stock | 6100 | $10.00 | 886,654.0000 | 295,164,515 | 0.68% | 0.00% |
| July 5, 2024 | AMICUS THERAPEUTICS, INC. | $FOLD | Campbell Bradley L | President and CEO | M | Common Stock | 6100 | $8.61 | 892,754.0000 | 295,164,515 | 0.69% | 0.00% |
| July 5, 2024 | AMICUS THERAPEUTICS, INC. | $FOLD | Campbell Bradley L | President and CEO | M | Stock Options (right to buy) | 6100 | $0.00 | 37,500.0000 | 295,164,515 | 13.99% | 0.00% |
| July 1, 2024 | AMICUS THERAPEUTICS, INC. | $FOLD | Campbell Bradley L | President and CEO | M | Common Stock | 1400 | $8.61 | 888,054.0000 | 295,164,515 | 0.16% | 0.00% |
| July 1, 2024 | AMICUS THERAPEUTICS, INC. | $FOLD | Campbell Bradley L | President and CEO | S | Common Stock | 1400 | $10.00 | 886,654.0000 | 295,164,515 | 0.16% | 0.00% |
| July 1, 2024 | AMICUS THERAPEUTICS, INC. | $FOLD | Campbell Bradley L | President and CEO | M | Stock Options (right to buy) | 1400 | $0.00 | 43,600.0000 | 295,164,515 | 3.11% | 0.00% |
| June 3, 2024 | AMICUS THERAPEUTICS, INC. | $FOLD | Campbell Bradley L | President and CEO | M | Stock Options (right to buy) | 7500 | $0.00 | 45,000.0000 | 295,164,515 | 14.29% | 0.00% |
| June 3, 2024 | AMICUS THERAPEUTICS, INC. | $FOLD | Campbell Bradley L | President and CEO | M | Common Stock | 7500 | $8.61 | 894,154.0000 | 295,164,515 | 0.85% | 0.00% |
| June 3, 2024 | AMICUS THERAPEUTICS, INC. | $FOLD | Campbell Bradley L | President and CEO | S | Common Stock | 7500 | $10.00 | 886,654.0000 | 295,164,515 | 0.84% | 0.00% |
| May 1, 2024 | AMICUS THERAPEUTICS, INC. | $FOLD | Campbell Bradley L | President and CEO | S | Common Stock | 7500 | $10.07 | 886,654.0000 | 295,164,515 | 0.84% | 0.00% |
| May 1, 2024 | AMICUS THERAPEUTICS, INC. | $FOLD | Campbell Bradley L | President and CEO | M | Common Stock | 7500 | $8.61 | 894,154.0000 | 295,164,515 | 0.85% | 0.00% |
| May 1, 2024 | AMICUS THERAPEUTICS, INC. | $FOLD | Campbell Bradley L | President and CEO | M | Stock Options (right to buy) | 7500 | $0.00 | 52,500.0000 | 295,164,515 | 12.50% | 0.00% |
| April 1, 2024 | AMICUS THERAPEUTICS, INC. | $FOLD | Campbell Bradley L | President and CEO | M | Common Stock | 7500 | $8.61 | 894,154.0000 | 295,164,515 | 0.85% | 0.00% |
| April 1, 2024 | AMICUS THERAPEUTICS, INC. | $FOLD | Campbell Bradley L | President and CEO | M | Stock Options (right to buy) | 7500 | $0.00 | 60,000.0000 | 295,164,515 | 11.11% | 0.00% |
| April 1, 2024 | AMICUS THERAPEUTICS, INC. | $FOLD | Campbell Bradley L | President and CEO | S | Common Stock | 7500 | $11.67 | 886,654.0000 | 295,164,515 | 0.84% | 0.00% |
| March 15, 2024 | AMICUS THERAPEUTICS, INC. | $FOLD | Campbell Bradley L | President and CEO | F | Common Stock | 13375 | $11.48 | 886,654.0000 | 295,164,515 | 1.49% | 0.00% |
| Jan. 9, 2024 | AMICUS THERAPEUTICS, INC. | $FOLD | Campbell Bradley L | President and CEO | F | Common Stock | 23577 | $13.65 | 904,196.0000 | 295,164,515 | 2.54% | 0.01% |
| Jan. 9, 2024 | AMICUS THERAPEUTICS, INC. | $FOLD | Campbell Bradley L | President and CEO | A | Common Stock | 28810 | $0.00 | 927,773.0000 | 295,164,515 | 3.20% | 0.01% |
| March 1, 2024 | AMICUS THERAPEUTICS, INC. | $FOLD | Campbell Bradley L | President and CEO | M | Common Stock | 8333 | $12.28 | 887,052.0000 | 295,164,515 | 0.95% | 0.00% |
| March 1, 2024 | AMICUS THERAPEUTICS, INC. | $FOLD | Campbell Bradley L | President and CEO | M | Common Stock | 7500 | $8.61 | 878,719.0000 | 295,164,515 | 0.86% | 0.00% |
| March 1, 2024 | AMICUS THERAPEUTICS, INC. | $FOLD | Campbell Bradley L | President and CEO | M | Stock Options (right to buy) | 8333 | $0.00 | 75,001.0000 | 295,164,515 | 10.00% | 0.00% |
| March 1, 2024 | AMICUS THERAPEUTICS, INC. | $FOLD | Campbell Bradley L | President and CEO | M | Stock Options (right to buy) | 7500 | $0.00 | 67,500.0000 | 295,164,515 | 10.00% | 0.00% |
| March 1, 2024 | AMICUS THERAPEUTICS, INC. | $FOLD | Campbell Bradley L | President and CEO | S | Common Stock | 15833 | $13.14 | 871,219.0000 | 295,164,515 | 1.78% | 0.01% |
| Feb. 15, 2024 | AMICUS THERAPEUTICS, INC. | $FOLD | Campbell Bradley L | President and CEO | S | Common Stock | 4167 | $14.00 | 871,219.0000 | 295,164,515 | 0.48% | 0.00% |
| Feb. 1, 2024 | AMICUS THERAPEUTICS, INC. | $FOLD | Campbell Bradley L | President and CEO | M | Common Stock | 7500 | $8.61 | 882,886.0000 | 295,164,515 | 0.86% | 0.00% |
| Feb. 1, 2024 | AMICUS THERAPEUTICS, INC. | $FOLD | Campbell Bradley L | President and CEO | M | Common Stock | 8333 | $12.28 | 891,219.0000 | 295,164,515 | 0.94% | 0.00% |
| Feb. 1, 2024 | AMICUS THERAPEUTICS, INC. | $FOLD | Campbell Bradley L | President and CEO | S | Common Stock | 15833 | $12.56 | 875,386.0000 | 295,164,515 | 1.78% | 0.01% |
| Feb. 1, 2024 | AMICUS THERAPEUTICS, INC. | $FOLD | Campbell Bradley L | President and CEO | M | Stock Options (right to buy) | 7500 | $0.00 | 75,000.0000 | 295,164,515 | 9.09% | 0.00% |
| Feb. 1, 2024 | AMICUS THERAPEUTICS, INC. | $FOLD | Campbell Bradley L | President and CEO | M | Stock Options (right to buy) | 8333 | $0.00 | 83,334.0000 | 295,164,515 | 9.09% | 0.00% |
| Jan. 9, 2024 | AMICUS THERAPEUTICS, INC. | $FOLD | Campbell Bradley L | President and CEO | F | Common Stock | 23577 | $13.65 | 875,386.0000 | 295,164,515 | 2.62% | 0.01% |
| Jan. 4, 2024 | AMICUS THERAPEUTICS, INC. | $FOLD | Campbell Bradley L | President and CEO | F | Common Stock | 7368 | $13.44 | 898,963.0000 | 295,164,515 | 0.81% | 0.00% |
| Jan. 2, 2024 | AMICUS THERAPEUTICS, INC. | $FOLD | Campbell Bradley L | President and CEO | A | Stock Options (right to buy) | 265517 | $0.00 | 265,517.0000 | 295,164,515 | 9999.99% | 0.09% |
| Jan. 2, 2024 | AMICUS THERAPEUTICS, INC. | $FOLD | Campbell Bradley L | President and CEO | M | Stock Options (right to buy) | 8333 | $0.00 | 91,667.0000 | 295,164,515 | 8.33% | 0.00% |
| Jan. 2, 2024 | AMICUS THERAPEUTICS, INC. | $FOLD | Campbell Bradley L | President and CEO | F | Common Stock | 15452 | $14.24 | 947,805.0000 | 295,164,515 | 1.60% | 0.01% |
| Jan. 2, 2024 | AMICUS THERAPEUTICS, INC. | $FOLD | Campbell Bradley L | President and CEO | M | Common Stock | 7500 | $8.61 | 955,305.0000 | 295,164,515 | 0.79% | 0.00% |
| Jan. 2, 2024 | AMICUS THERAPEUTICS, INC. | $FOLD | Campbell Bradley L | President and CEO | S | Common Stock | 7500 | $14.24 | 947,805.0000 | 295,164,515 | 0.79% | 0.00% |
| Jan. 2, 2024 | AMICUS THERAPEUTICS, INC. | $FOLD | Campbell Bradley L | President and CEO | M | Common Stock | 8333 | $12.28 | 956,138.0000 | 295,164,515 | 0.88% | 0.00% |
| Jan. 2, 2024 | AMICUS THERAPEUTICS, INC. | $FOLD | Campbell Bradley L | President and CEO | S | Common Stock | 8333 | $14.23 | 947,805.0000 | 295,164,515 | 0.87% | 0.00% |
| Jan. 3, 2024 | AMICUS THERAPEUTICS, INC. | $FOLD | Campbell Bradley L | President and CEO | F | Common Stock | 41474 | $13.53 | 906,331.0000 | 295,164,515 | 4.38% | 0.01% |
| Jan. 2, 2024 | AMICUS THERAPEUTICS, INC. | $FOLD | Campbell Bradley L | President and CEO | M | Stock Options (right to buy) | 7500 | $0.00 | 82,500.0000 | 295,164,515 | 8.33% | 0.00% |
| Jan. 2, 2024 | AMICUS THERAPEUTICS, INC. | $FOLD | Campbell Bradley L | President and CEO | A | Common Stock | 153810 | $0.00 | 963,257.0000 | 295,164,515 | 19.00% | 0.05% |
| Dec. 18, 2023 | AMICUS THERAPEUTICS, INC. | $FOLD | Campbell Bradley L | President and CEO | A | Common Stock | 17286 | $0.00 | 809,447.0000 | 289,057,198 | 2.18% | 0.01% |
| Dec. 1, 2023 | AMICUS THERAPEUTICS, INC. | $FOLD | Campbell Bradley L | President and CEO | S | Common Stock | 11702 | $11.08 | 792,161.0000 | 289,057,198 | 1.46% | 0.00% |
| Dec. 1, 2023 | AMICUS THERAPEUTICS, INC. | $FOLD | Campbell Bradley L | President and CEO | M | Common Stock | 11702 | $2.94 | 803,863.0000 | 289,057,198 | 1.48% | 0.00% |
| Dec. 1, 2023 | AMICUS THERAPEUTICS, INC. | $FOLD | Campbell Bradley L | President and CEO | M | Stock Options (right to buy) | 11702 | $0.00 | 0.0000 | 289,057,198 | 100.00% | 0.00% |
| Nov. 1, 2023 | AMICUS THERAPEUTICS, INC. | $FOLD | Campbell Bradley L | President and CEO | S | Common Stock | 11700 | $10.97 | 792,161.0000 | 289,057,198 | 1.46% | 0.00% |
| Nov. 1, 2023 | AMICUS THERAPEUTICS, INC. | $FOLD | Campbell Bradley L | President and CEO | M | Common Stock | 11700 | $2.94 | 803,861.0000 | 289,057,198 | 1.48% | 0.00% |
| Nov. 1, 2023 | AMICUS THERAPEUTICS, INC. | $FOLD | Campbell Bradley L | President and CEO | M | Stock Options (right to buy) | 11700 | $0.00 | 11,702.0000 | 289,057,198 | 50.00% | 0.00% |
| Oct. 2, 2023 | AMICUS THERAPEUTICS, INC. | $FOLD | Campbell Bradley L | President & CEO | M | Stock Options (right to buy) | 11700 | $0.00 | 23,402.0000 | 289,057,198 | 33.33% | 0.00% |
| Oct. 2, 2023 | AMICUS THERAPEUTICS, INC. | $FOLD | Campbell Bradley L | President & CEO | M | Common Stock | 11700 | $2.94 | 803,861.0000 | 289,057,198 | 1.48% | 0.00% |
| Oct. 2, 2023 | AMICUS THERAPEUTICS, INC. | $FOLD | Campbell Bradley L | President & CEO | S | Common Stock | 11200 | $11.20 | 792,661.0000 | 289,057,198 | 1.39% | 0.00% |
| Oct. 2, 2023 | AMICUS THERAPEUTICS, INC. | $FOLD | Campbell Bradley L | President & CEO | S | Common Stock | 500 | $12.04 | 792,161.0000 | 289,057,198 | 0.06% | 0.00% |
| Sept. 1, 2023 | AMICUS THERAPEUTICS, INC. | $FOLD | Campbell Bradley L | President & CEO | M | Stock Options (right to buy) | 11700 | $0.00 | 35,102.0000 | 289,057,198 | 25.00% | 0.00% |
| Sept. 1, 2023 | AMICUS THERAPEUTICS, INC. | $FOLD | Campbell Bradley L | President & CEO | M | Common Stock | 11700 | $2.94 | 810,254.0000 | 289,057,198 | 1.47% | 0.00% |
| Sept. 1, 2023 | AMICUS THERAPEUTICS, INC. | $FOLD | Campbell Bradley L | President & CEO | S | Common Stock | 18093 | $12.97 | 792,161.0000 | 289,057,198 | 2.23% | 0.01% |
| Aug. 1, 2023 | AMICUS THERAPEUTICS, INC. | $FOLD | Campbell Bradley L | President & CEO | M | Stock Options (right to buy) | 11700 | $0.00 | 46,802.0000 | 289,057,198 | 20.00% | 0.00% |
| Aug. 1, 2023 | AMICUS THERAPEUTICS, INC. | $FOLD | Campbell Bradley L | President & CEO | S | Common Stock | 20000 | $13.39 | 798,554.0000 | 289,057,198 | 2.44% | 0.01% |
| Aug. 1, 2023 | AMICUS THERAPEUTICS, INC. | $FOLD | Campbell Bradley L | President & CEO | M | Common Stock | 11700 | $2.94 | 818,554.0000 | 289,057,198 | 1.45% | 0.00% |
| July 13, 2023 | AMICUS THERAPEUTICS, INC. | $FOLD | Campbell Bradley L | President & CEO | S | Common Stock | 6800 | $12.51 | 806,854.0000 | 289,057,198 | 0.84% | 0.00% |
| July 12, 2023 | AMICUS THERAPEUTICS, INC. | $FOLD | Campbell Bradley L | President & CEO | S | Common Stock | 1500 | $12.51 | 813,654.0000 | 289,057,198 | 0.18% | 0.00% |
| July 3, 2023 | AMICUS THERAPEUTICS, INC. | $FOLD | Campbell Bradley L | President & CEO | M | Stock Options (right to buy) | 11700 | $0.00 | 58,502.0000 | 289,057,198 | 16.67% | 0.00% |
| July 3, 2023 | AMICUS THERAPEUTICS, INC. | $FOLD | Campbell Bradley L | President & CEO | M | Common Stock | 11700 | $2.94 | 826,854.0000 | 289,057,198 | 1.44% | 0.00% |
| July 3, 2023 | AMICUS THERAPEUTICS, INC. | $FOLD | Campbell Bradley L | President & CEO | S | Common Stock | 11700 | $12.31 | 815,154.0000 | 289,057,198 | 1.42% | 0.00% |
| June 6, 2023 | AMICUS THERAPEUTICS, INC. | $FOLD | Campbell Bradley L | President & CEO | S | Common Stock | 8300 | $12.50 | 815,154.0000 | 289,057,198 | 1.01% | 0.00% |
| June 1, 2023 | AMICUS THERAPEUTICS, INC. | $FOLD | Campbell Bradley L | President & CEO | M | Stock Options (right to buy) | 7125 | $0.00 | 0.0000 | 289,057,198 | 100.00% | 0.00% |
| June 1, 2023 | AMICUS THERAPEUTICS, INC. | $FOLD | Campbell Bradley L | President & CEO | M | Common Stock | 4575 | $2.94 | 835,154.0000 | 289,057,198 | 0.55% | 0.00% |
| June 1, 2023 | AMICUS THERAPEUTICS, INC. | $FOLD | Campbell Bradley L | President & CEO | M | Common Stock | 7125 | $2.45 | 830,579.0000 | 289,057,198 | 0.87% | 0.00% |
| June 1, 2023 | AMICUS THERAPEUTICS, INC. | $FOLD | Campbell Bradley L | President & CEO | S | Common Stock | 11700 | $11.36 | 823,454.0000 | 289,057,198 | 1.40% | 0.00% |
| June 1, 2023 | AMICUS THERAPEUTICS, INC. | $FOLD | Campbell Bradley L | President & CEO | M | Stock Options (right to buy) | 4575 | $0.00 | 70,202.0000 | 289,057,198 | 6.12% | 0.00% |
| May 1, 2023 | AMICUS THERAPEUTICS, INC. | $FOLD | Campbell Bradley L | President & CEO | M | Stock Options (right to buy) | 11700 | $0.00 | 7,125.0000 | 289,057,198 | 62.15% | 0.00% |
| May 1, 2023 | AMICUS THERAPEUTICS, INC. | $FOLD | Campbell Bradley L | President & CEO | M | Common Stock | 11700 | $2.45 | 835,154.0000 | 289,057,198 | 1.42% | 0.00% |
| May 1, 2023 | AMICUS THERAPEUTICS, INC. | $FOLD | Campbell Bradley L | President & CEO | S | Common Stock | 11700 | $11.80 | 823,454.0000 | 289,057,198 | 1.40% | 0.00% |
| April 3, 2023 | AMICUS THERAPEUTICS, INC. | $FOLD | Campbell Bradley L | President & CEO | M | Common Stock | 11700 | $2.45 | 835,154.0000 | 289,057,198 | 1.42% | 0.00% |
| April 3, 2023 | AMICUS THERAPEUTICS, INC. | $FOLD | Campbell Bradley L | President & CEO | S | Common Stock | 11700 | $11.21 | 823,454.0000 | 289,057,198 | 1.40% | 0.00% |
| April 3, 2023 | AMICUS THERAPEUTICS, INC. | $FOLD | Campbell Bradley L | President & CEO | M | Stock Options (right to buy) | 11700 | $0.00 | 18,825.0000 | 289,057,198 | 38.33% | 0.00% |
| March 15, 2023 | AMICUS THERAPEUTICS, INC. | $FOLD | Campbell Bradley L | President & CEO | F | Common Stock | 13375 | $11.43 | 823,454.0000 | 289,057,198 | 1.60% | 0.00% |
| March 1, 2023 | AMICUS THERAPEUTICS, INC. | $FOLD | Campbell Bradley L | President & CEO | S | Common Stock | 4544 | $13.68 | 836,829.0000 | 289,057,198 | 0.54% | 0.00% |
| March 1, 2023 | AMICUS THERAPEUTICS, INC. | $FOLD | Campbell Bradley L | President & CEO | M | Common Stock | 11700 | $2.45 | 856,829.0000 | 289,057,198 | 1.38% | 0.00% |
| March 1, 2023 | AMICUS THERAPEUTICS, INC. | $FOLD | Campbell Bradley L | President & CEO | S | Common Stock | 15456 | $13.12 | 841,373.0000 | 289,057,198 | 1.80% | 0.01% |
| March 1, 2023 | AMICUS THERAPEUTICS, INC. | $FOLD | Campbell Bradley L | President & CEO | M | Stock Options (right to buy) | 11700 | $0.00 | 30,525.0000 | 289,057,198 | 27.71% | 0.00% |
| Feb. 1, 2023 | AMICUS THERAPEUTICS, INC. | $FOLD | Campbell Bradley L | President & CEO | M | Stock Options (right to buy) | 11700 | $0.00 | 42,225.0000 | 289,057,198 | 21.70% | 0.00% |
| Feb. 1, 2023 | AMICUS THERAPEUTICS, INC. | $FOLD | Campbell Bradley L | President & CEO | S | Common Stock | 20000 | $12.98 | 845,129.0000 | 289,057,198 | 2.31% | 0.01% |
| Feb. 1, 2023 | AMICUS THERAPEUTICS, INC. | $FOLD | Campbell Bradley L | President & CEO | M | Common Stock | 11700 | $2.45 | 865,129.0000 | 289,057,198 | 1.37% | 0.00% |
| Jan. 11, 2023 | AMICUS THERAPEUTICS, INC. | $FOLD | Campbell Bradley L | President & CEO | A | Common Stock | 98040 | $0.00 | 903,576.0000 | 289,057,198 | 12.17% | 0.03% |
| Jan. 11, 2023 | AMICUS THERAPEUTICS, INC. | $FOLD | Campbell Bradley L | President & CEO | F | Common Stock | 50147 | $12.02 | 853,429.0000 | 289,057,198 | 5.55% | 0.02% |
| Jan. 9, 2023 | AMICUS THERAPEUTICS, INC. | $FOLD | Campbell Bradley L | President & CEO | M | Stock Options (right to buy) | 11700 | $0.00 | 53,925.0000 | 289,057,198 | 17.83% | 0.00% |
| Jan. 9, 2023 | AMICUS THERAPEUTICS, INC. | $FOLD | Campbell Bradley L | President & CEO | M | Common Stock | 11700 | $2.45 | 817,236.0000 | 289,057,198 | 1.45% | 0.00% |
| Jan. 9, 2023 | AMICUS THERAPEUTICS, INC. | $FOLD | Campbell Bradley L | President & CEO | S | Common Stock | 11700 | $11.43 | 805,536.0000 | 289,057,198 | 1.43% | 0.00% |
| Jan. 4, 2023 | AMICUS THERAPEUTICS, INC. | $FOLD | Campbell Bradley L | President & CEO | F | Common Stock | 7094 | $12.03 | 805,536.0000 | 289,057,198 | 0.87% | 0.00% |
| Jan. 3, 2023 | AMICUS THERAPEUTICS, INC. | $FOLD | Campbell Bradley L | President & CEO | A | Common Stock | 169635 | $0.00 | 831,678.0000 | 289,057,198 | 25.62% | 0.06% |
| Jan. 2, 2023 | AMICUS THERAPEUTICS, INC. | $FOLD | Campbell Bradley L | President & CEO | F | Common Stock | 27575 | $12.21 | 662,043.0000 | 289,057,198 | 4.00% | 0.01% |
| Jan. 3, 2023 | AMICUS THERAPEUTICS, INC. | $FOLD | Campbell Bradley L | President & CEO | F | Common Stock | 19048 | $11.93 | 812,630.0000 | 289,057,198 | 2.29% | 0.01% |
| Jan. 3, 2023 | AMICUS THERAPEUTICS, INC. | $FOLD | Campbell Bradley L | President & CEO | A | Stock Options (right to buy) | 301109 | $0.00 | 301,109.0000 | 289,057,198 | 9999.99% | 0.10% |